Sam Altman’s September 12 statements to Fortune have sharply reduced trader expectations for an OpenAI IPO in 2026, with the CEO describing a public listing this year as “ill-advised” due to urgent work on AI safety, alignment, and potential industry-government coordination. OpenAI confidentially filed IPO paperwork in June while targeting a roughly $1 trillion valuation, yet Altman emphasized the company feels no pressure to accelerate and prefers remaining private amid rapid capability advances. Rival Anthropic continues preparations for its own debut, highlighting competitive pressure for capital. Key near-term catalysts include any formal safety agreements among frontier labs and clarity on 2027 timing.
Eksperymentalne podsumowanie AI odwołujące się do danych Polymarket. To nie jest porada handlowa i nie ma wpływu na rozstrzyganie tego rynku. · ZaktualizowanoOpenAI CEO Sam Altman states 2026 IPO is ill-advised due to AI safety concerns
September 30, 2026 plunges to 0%46%
In an interview, Sam Altman said that given current AI safety and alignment issues, an IPO in 2026 would be ill-advised, effectively pushing the IPO timeline beyond 2026 and causing market confidence in near-term IPOs to decline.
OpenAI CEO Sam Altman says 2026 IPO is ill-advised due to AI safety concerns
September 30, 2026 plunges to 0%50%
In an interview, Sam Altman stated that given current AI safety and alignment challenges, an IPO in 2026 would be ill-advised, effectively delaying the public offering to 2027 and causing market skepticism about a 2026 listing.




Uważaj na linki zewnętrzne.
Uważaj na linki zewnętrzne.
Często zadawane pytania